Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Yaxun Sun,Jingjun Zhou,Hongkun Wang,Hao Wang,Xianzhen Chen,Tingyu Gong,Ping Liang,Chenyang Jiang
DOI: https://doi.org/10.1016/j.scr.2022.102898
IF: 1.587
2022-01-01
Stem Cell Research
Abstract:Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease characterized by left ventricular hypertrophy and a high risk of sudden death. In this study, a skin biopsy was obtained from a HCM patient harboring a heterozygous missense mutation (c.3764C>A; p.A1225D) in the myosin binding protein C3 (MYBPC3) gene. The isolated fibroblasts were reprogrammed using non-integrated Sendai viral method to establish the patient-specific induced pluripotent stem cell (iPSC) line. The established iPSC line displayed normal morphology and karyotype, expressed pluripotency markers, and can differentiate into three germ layers in vivo.
What problem does this paper attempt to address?